date/time interval
- September 15, 2025 - August 31, 2027
Fast Track Phase II - Platform technology to identify and develop first-in-class anti-fibrotic therapeutics through inhibition of collagen CP4H
Grant
Overview
awarded by
administered by
sponsor award ID
- 4 R42 HL176297-02
Affiliation
contributor
- Silver, Randi B. Principal Investigator (Subaward) 2025 - 2027